Inaktiver Wert

Andere Sprachen Arix Bioscience plc

Aktien

A2DL9L

GB00BD045071

ARIX

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Merck Sharp & Dohme LLC completed the acquisition of Harpoon Therapeutics, Inc..	11.03.
RTW Biotech Opportunities NAV increases 2.5% in January	14.02.
RTW Biotech Opportunities Completes Arix Bioscience Acquisition	13.02.
RTW Biotech Opportunities Ltd a fund managed by RTW Investments, LP completed the acquisition of Arix Biosciences Plc's assets from Arix Bioscience plc.	13.02.
Katoro Gold launches fundraising, eyes board shake-up	12.02.
Arix Bioscience's Asset Sale to RTW Biotech Takes Effect	12.02.
Arix Bioscience shares suspended ahead of RTW takeover	12.02.
Arix Bioscience Shares to be Suspended on London Exchange Amid Acquisition	12.02.
Arix Bioscience Shareholders Approve Asset Sale to RTW Biotech	29.01.
Arix Bioscience Gains UK Regulatory Approval for Sale to RTW Biotech	23.01.
RTW Biotech completes Arix investment in takeover run-up	22.01.
Arix Bioscience plc Announces Resignation of Directors	22.01.
Arix Bioscience eyes USD19 million return from Harpoon sale	19.01.
Arix Bioscience Flags Proceeds from Merck's Purchase of Harpoon Therapeutics	19.01.
Rtw Biotech Opportunities Operating Ltd completed the acquisition of a 26.6% stake in Arix Bioscience plc from Acacia Research Corporation for £47.2 million.	19.01.
Arix Bioscience's Portfolio Company Signs $680 Million Takeover Deal with Merck & Co.	09.01.
Arix Bioscience's Portfolio Company Doses First Patient in Late-stage Trial of Choroidal Melanoma Therapy	08.12.
RTW Biotech agrees "immediately accretive" Arix Bioscience takeover	01.11.
RTW Biotech Opportunities, Arix Bioscience Agree on Potential Merger Terms	01.11.
Transcript : RTW Biotech Opportunities Ltd, Arix Bioscience plc - Pre Recorded M&A Call	01.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Arix Bioscience plc

Aktien

A2DL9L

GB00BD045071

ARIX

Andere Sprachen

Filter